Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease. (2021)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(21)00374-5
PubMed Identifier: 34653395
Publication URI: http://europepmc.org/abstract/MED/34653395
Type: Journal Article/Review
Volume: 6
Parent Publication: The lancet. Gastroenterology & hepatology
Issue: 12